Large-scale testing (Phase 3)Ended earlyNCT01012297
What this trial is testing
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
Who this might be right for
Recurrent Uterine Corpus SarcomaStage IIIA Uterine SarcomaStage IIIB Uterine Sarcoma+4 more
National Cancer Institute (NCI) 107